Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec 15;14(24):6203.
doi: 10.3390/cancers14246203.

Natural Products/Bioactive Compounds as a Source of Anticancer Drugs

Affiliations
Review

Natural Products/Bioactive Compounds as a Source of Anticancer Drugs

Syeda Tasmia Asma et al. Cancers (Basel). .

Abstract

Cancer is one of the major deadly diseases globally. The alarming rise in the mortality rate due to this disease attracks attention towards discovering potent anticancer agents to overcome its mortality rate. The discovery of novel and effective anticancer agents from natural sources has been the main point of interest in pharmaceutical research because of attractive natural therapeutic agents with an immense chemical diversity in species of animals, plants, and microorganisms. More than 60% of contemporary anticancer drugs, in one form or another, have originated from natural sources. Plants and microbial species are chosen based on their composition, ecology, phytochemical, and ethnopharmacological properties. Plants and their derivatives have played a significant role in producing effective anticancer agents. Some plant derivatives include vincristine, vinblastine, irinotecan, topotecan, etoposide, podophyllotoxin, and paclitaxel. Based on their particular activity, a number of other plant-derived bioactive compounds are in the clinical development phase against cancer, such as gimatecan, elomotecan, etc. Additionally, the conjugation of natural compounds with anti-cancerous drugs, or some polymeric carriers particularly targeted to epitopes on the site of interest to tumors, can generate effective targeted treatment therapies. Cognizance from such pharmaceutical research studies would yield alternative drug development strategies through natural sources which could be economical, more reliable, and safe to use.

Keywords: anticancer drugs; medicinal mushrooms; medicinal plants; natural products.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Some medicinal plants and their bioactive compounds having potential anticancer properties.
Figure 2
Figure 2
Chemical structures of (a) vinblastine, (b) vincristine, (c) vinorelbine, (d) vinflunine, (e) berbamine, and (f) veratridine.
Figure 3
Figure 3
Chemical structures of (a) camptothecin, (b) irinotecan, (c) diflomotecan, and (d) topotecan.
Figure 4
Figure 4
Chemical structures of (a) podophyllotoxin, (b) etoposide, and (c) teniposide.
Figure 5
Figure 5
Chemical structures of (a) paclitaxel, (b) cabazitaxel, and (c) docetaxel.

References

    1. Tan G., Gyllenhaal C., Soejarto D. Biodiversity as a source of anticancer drugs. Curr. Drug Targets. 2006;7:265–277. doi: 10.2174/138945006776054942. - DOI - PubMed
    1. De Mesquita M.L., de Paula J.E., Pessoa C., de Moraes M.O., Costa-Lotufo L.V., Grougnet R., Michel S., Tillequin F., Espindola L.S. Cytotoxic activity of Brazilian Cerrado plants used in traditional medicine against cancer cell lines. J. Ethnopharmacol. 2009;123:439–445. doi: 10.1016/j.jep.2009.03.018. - DOI - PubMed
    1. Hong W.K., Sporn M.B. Recent advances in chemoprevention of cancer. Science. 1997;278:1073–1077. doi: 10.1126/science.278.5340.1073. - DOI - PubMed
    1. Chandra S. Endophytic fungi: Novel sources of anticancer lead molecules. Appl. Microbiol. Biotechnol. 2012;95:47–59. doi: 10.1007/s00253-012-4128-7. - DOI - PubMed
    1. Srivastava V., Negi A.S., Kumar J., Gupta M., Khanuja S.P. Plant-based anticancer molecules: A chemical and biological profile of some important leads. Bioorg. Med. Chem. 2005;13:5892–5908. doi: 10.1016/j.bmc.2005.05.066. - DOI - PubMed

LinkOut - more resources